Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Japanese Red Cross PT-GVHD Study Group
- PMID: 7907679
- DOI: 10.1016/s0140-6736(94)91580-6
Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Japanese Red Cross PT-GVHD Study Group
Abstract
We distributed a questionnaire to highlight the effects of post transfusion graft-versus-host disease (PT-GVHD) and to elucidate the risk factors that would predispose people to the disease. The questionnaire described the pathogenesis and the clinical profiles of PT-GVHD and was distributed to doctors in Japan whose hospital conducted more than 1000 units of blood transfusions a year. Doctors were asked about their awareness and experience of PT-GVHD cases. Those who had seen cases of PT-GVHD were then asked to detail clinical course and laboratory data. Of the 14,083 doctors who replied to the first question, 47.4% did not realise that PT-GVHD could occur in immunocompetent hosts. From 304 cases where detailed information was supplied, 171 were considered clinically compatible with PT-GVHD. From these it seems that the risk factors linked to PT-GVHD are cardiovascular surgery, cancer, fresh and consanguineous blood transfusion, and being male. Patients with any of these factors should have some prophylactic therapy such as irradiation of blood before transfusion.
Comment in
-
Prevention of transfusion-associated graft-versus-host disease.Lancet. 1994 May 28;343(8909):1365-6. doi: 10.1016/s0140-6736(94)92503-8. Lancet. 1994. PMID: 7910356 No abstract available.
Similar articles
-
Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-vs.-host disease in Japan.Transfus Med. 2000 Dec;10(4):315-20. doi: 10.1046/j.1365-3148.2000.00264.x. Transfus Med. 2000. PMID: 11123816
-
Posttransfusion graft-versus-host disease in Japanese newborns.Transfusion. 1996 Feb;36(2):117-23. doi: 10.1046/j.1537-2995.1996.36296181922.x. Transfusion. 1996. PMID: 8614960 Review.
-
[Institution and significance of the new guidelines for prevention of transfusion associated graft versus host disease].Nihon Rinsho. 1997 Sep;55(9):2296-304. Nihon Rinsho. 1997. PMID: 9301293 Japanese.
-
Transfusion-associated graft-versus-host disease with transfusion practice in cardiac surgery.J Cardiovasc Surg (Torino). 2000 Jun;41(3):377-80. J Cardiovasc Surg (Torino). 2000. PMID: 10952326
-
Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem.J Intensive Care Med. 2015 Mar;30(3):123-30. doi: 10.1177/0885066613492645. Epub 2013 Jun 20. J Intensive Care Med. 2015. PMID: 23792801 Review.
Cited by
-
Haemorrhagic complications of vitamin k antagonists in the elderly: risk factors and management.Drugs Aging. 2006;23(1):13-25. doi: 10.2165/00002512-200623010-00002. Drugs Aging. 2006. PMID: 16492066 Review.
-
[Aprotinin and recombinant human erythropoietin reduce the need for homologous blood transfusion in cardiac surgery].Jpn J Thorac Cardiovasc Surg. 1998 Sep;46(9):846-53. doi: 10.1007/BF03217832. Jpn J Thorac Cardiovasc Surg. 1998. PMID: 9796284 Japanese.
-
Engineering Therapeutic T Cells: From Synthetic Biology to Clinical Trials.Annu Rev Pathol. 2017 Jan 24;12:305-330. doi: 10.1146/annurev-pathol-052016-100304. Epub 2016 Dec 5. Annu Rev Pathol. 2017. PMID: 27959633 Free PMC article. Review.
-
Properties of stored red blood cells: understanding immune and vascular reactivity.Transfusion. 2011 Apr;51(4):894-900. doi: 10.1111/j.1537-2995.2011.03103.x. Transfusion. 2011. PMID: 21496052 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical